C2i Genomics launched its C2inform minimal residual disease test across Europe after obtaining CE-IVD marking in the EU, UK, and Switzerland. The company also announced the completion of several clinical trials.Â
Cancer centers don’t usually ask NCI to increase their catchment areas. That’s because including more people and more square miles means increasing the responsibility to show impact.
In a move that appears to prioritize biomedical engineering over cancer research, President Joe Biden’s proposal for fiscal year 2023 cuts NCI funding by $199 million, a 2.9% percent cut from the current year’s level.
Worry not, because support for cancer research remains strong, NCI Director Ned Sharpless said, even as the institute stalls in its attempts to increase paylines in fiscal year 2022 and as the White House requests a nearly $200 million cutto the FY23 NCI budget.
The FY22 spending bill increases NCI’s budget by $159 million—but according to NCI officials, this boost isn’t sufficient to raise paylines for R01 grants for established and new investigators.
The American Society of Clinical Oncology and Conquer Cancer, the ASCO Foundation, will recognize the following award recipients at the 2022 ASCO Annual Meeting in Chicago: Â
American Cancer Society CEO Karen Knudsen was named the 2022 ResearcHERS: Women Fighting Cancer National Ambassador.Â
Bassel El-Rayes was named deputy director of the O’Neal Comprehensive Cancer Center at UAB.
The Albert Einstein Cancer Center appointed three faculty members to leadership positions: Ulrich G. Steidl as deputy director, Adebola A. Adedimeji as the inaugural associate director for diversity, equity, and inclusion, and H. Dean Hosgood as co-leader of AECC’s cancer epidemiology, prevention, and control research program.Â
